Patents by Inventor Sabrina PETER

Sabrina PETER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutants of the bacteriophage lambda integrase
    Patent number: 11414681
    Abstract: The present invention refers to lambda integrases comprising at least one amino acid mutation at positions 43, 319 and 336 of the lambda integrase as set forth in SEQ ID NO: 1. The invention further refers to nucleic acid molecules comprising the nucleotide sequence encoding the mutant lambda integrase and to host cells containing these nucleic acid molecules. The invention also refers to methods of recombining a nucleic acid of interest into a target nucleic acid in the presence of the mutant lambda integrase and sequence specific recombination kits.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: August 16, 2022
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Farid Ghadessy, Jia Wei Siau, Peter Droge, Harshyaa Makhija, Shree Harsh Vijaya Chandra, Sabrina Peter
  • MUTANTS OF THE BACTERIOPHAGE LAMBDA INTEGRASE
    Publication number: 20200063165
    Abstract: The present invention refers to lambda integrases comprising at least one amino acid mutation at positions 43, 319 and 336 of the lambda integrase as set forth in SEQ ID NO: 1. The invention further refers to nucleic acid molecules comprising the nucleotide sequence encoding the mutant lambda integrase and to host cells containing these nucleic acid molecules. The invention also refers to methods of recombining a nucleic acid of interest into a target nucleic acid in the presence of the mutant lambda integrase and sequence specific recombination kits.
    Type: Application
    Filed: June 3, 2019
    Publication date: February 27, 2020
    Inventors: Farid GHADESSY, Jia Wei SLAU, Peter DROGE, Harshyaa MAKHIJA, Shree Harsh VIJAYA CHANDRA, Sabrina PETER
  • Mutants of the bacteriophage lambda integrase
    Patent number: 10344301
    Abstract: The present invention refers to lambda integrases comprising at least one amino acid mutation at positions 43, 319 and 336 of the lambda integrase as set forth in SEQ ID NO: 1. The invention further refers to nucleic acid molecules comprising the nucleotide sequence encoding the mutant lambda integrase and to host cells containing these nucleic acid molecules. The invention also refers to methods of recombining a nucleic acid of interest into a target nucleic acid in the presence of the mutant lambda integrase and sequence specific recombination kits.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: July 9, 2019
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Farid Ghadessy, Jia Wei Siau, Peter Droge, Harshyaa Makhija, Shree Harsh Vijaya Chandra, Sabrina Peter
  • MUTANTS OF THE BACTERIOPHAGE LAMBDA INTEGRASE
    Publication number: 20170327847
    Abstract: The present invention refers to lambda integrases comprising at least one amino acid mutation at positions 43, 319 and 336 of the lambda integrase as set forth in SEQ ID NO: 1. The invention further refers to nucleic acid molecules comprising the nucleotide sequence encoding the mutant lambda integrase and to host cells containing these nucleic acid molecules. The invention also refers to methods of recombining a nucleic acid of interest into a target nucleic acid in the presence of the mutant lambda integrase and sequence specific recombination kits.
    Type: Application
    Filed: August 11, 2015
    Publication date: November 16, 2017
    Inventors: Farid GHADESSY, Jia Wei SIAU, Peter DROGE, Harshyaa MAKHIJA, Shree Harsh VIJAYA CHANDRA, Sabrina PETER